Ibotta (IBTA) Q2 Earnings: What To Expect

Ibotta (NYSE: IBTA) is set to report Q2 earnings Monday. Last quarter, it posted revenue of $82.48 million, down 2.5% YoY, and 70.69 million total redemptions, down 14.6% YoY, with an EPS miss. For this quarter, analysts expect revenue down 1.3% YoY. The average analyst price target is $33.43 versus a $24 share price.

Original reporting
Published Aug 2, 2026, 4:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 2, 2026, 5:08 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ibotta (IBTA) Q2 Earnings: What To Expect — source image
Decision brief

The 30-second read

$IBTANeutralMed
01

Why it matters

Traders can use the provided consensus direction (revenue -1.3% YoY) and the company’s recent pattern of revenue misses to frame scenarios for the upcoming earnings reaction.

02

Market read

The main tradable element is the earnings timing and the setup around expected revenue decline and prior revenue misses, which can drive volatility into the print.

03

What to watch

No detail is provided on margins, guidance, or cash flow, which are often the real drivers of post-earnings repricing for cash-back/rewards platforms.

Relevance 4/10Novelty 4/10Timing: ahead of Monday afternoon earnings

Background

The article is a pre-earnings checklist for Ibotta, referencing last quarter’s revenue and EPS miss, plus redemption trends and peer Q2 results.

Company-level read

Ticker impact

$IBTANeutralMedium confidence
Context

Ibotta is set to report earnings Monday afternoon, with expectations for revenue to decline 1.3% YoY and recent redemption weakness.

Expected impact

High volatility possible around the print, with downside risk if revenue and redemptions fail to stabilize.

Evidence & confidence

The text provides consensus direction (revenue -1.3% YoY) plus recent underperformance signals (multiple revenue misses, redemptions down 14.6% YoY), but it does not include any new guidance or fresh company-specific disclosure beyond the upcoming report.

Market effects

Limited, since the piece only uses peer results as directional context rather than reporting new sector-wide regulatory or demand shifts.

None specified; focus is US-listed Ibotta earnings timing.

None specified; no international expansion or cross-border policy changes mentioned.

Counterpoint

The article highlights revenue decline expectations, but the stock’s large recent drawdown could mean the market is already pricing weakness, making upside possible if redemptions stabilize.

Key entities

  • Ibotta

    Cash-back rewards platform reporting Q2 earnings Monday afternoon; last quarter showed revenue down 2.5% YoY and redemptions down 14.6% YoY.

  • MediaAlpha

    Peer cited as having delivered Q2 revenue growth and a post-results stock decline.

  • Omnicom Group

    Peer cited as having reported revenue growth and a post-results stock decline.

Related articles

$IBTAMed

Ibotta, Inc. (IBTA): Results of Operations and Financial Condition

Ibotta, Inc. (IBTA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 earningsrelease63026.htm EX-99.1 Document Ibotta Reports Second Quarter 2026 Financial Results Ibotta’s second quarter financial results exceeded the upper end of the guidance range for both revenue and adjusted EBITDA Revenue grew by 3% year-over-year to $88.9 million

$MATVMed

Mativ Q2 Earnings Call Highlights

Mativ (NYSE:MATV) reported Q2 adjusted EBITDA of $50 million, up more than 18%, and segment margin up 210 bps to 15.3% as pricing offset inflation. Healthcare operations at its Knoxville facility normalized after an outage. Net debt fell to $908 million and net leverage improved to 3.8x. A Menasha, Wisconsin tornado is expected to cut Q3 sales by $20M to $25M.

$MAINMed

Main Street Capital Q2 Earnings Call Highlights

Main Street Capital (NYSE:MAIN) reported Q2 results on an earnings call. Total investment income was $149.6M (+3.9% YoY, +6.8% QoQ). DNII before taxes was $1.08/share; CFO expects at least $0.97/share in Q3. The board declared a $0.30 supplemental dividend and regular monthly dividends of $0.265/share. MAIN invested about $100M in lower middle market deals and $239M in private loans.

$LTMMedAI 8/10

LATAM Airlines Group Q2 Earnings Call Highlights

LATAM Airlines Group reported Q2 net income of $125 million and adjusted operating cash flow of $476 million, with nearly $150 million positive cash change before dividends. The company said premium revenue was 29% of passenger revenue and LATAM Pass generated over 67% of passenger revenue. It reinstated 2026 guidance: revenue $17.3B to $17.7B and adjusted EBITDA $4.1B to $4.4B, plus 9% to 10% capacity growth.

$MAGNMed

Magnera Q3 Earnings Call Highlights

Magnera (NYSE:MAGN) reported Q3 updates on infrastructure and filtration-related sales, with Americas revenue essentially flat year over year. Adjusted EBITDA rose 16% to $71 million in the Americas. The company reaffirmed full-year free cash flow of about $90M to $110M, but expects full-year adjusted EBITDA toward the low end of its prior range, citing inflation and macro uncertainty.

$LPXMedAI 8/10

Louisiana-Pacific Q2 Earnings Call Highlights

Louisiana-Pacific (NYSE:LPX) reported Q2 siding volume down 12% for primed siding and up 1% for ExpertFinish. CFO Alan Haughie said higher prices added $27M to siding revenue and EBITDA, while lower volumes cut $46M revenue and $24M EBITDA. LP guided Q3 siding revenue $460M-$470M and EBITDA $110M-$120M, reaffirming full-year siding guidance. OSB prices missed guidance by about $15; LP expects negative OSB EBITDA.